Senior Leadership

凯文·卡伦博士在2004年被任命为UMCCC的主任。Cullen博士作为临床科学家享有盛誉，对头颈癌生物学以及药物作用和耐药性机制感兴趣。此前，他曾担任华盛顿乔治敦大学隆巴迪综合癌症中心的代理主任。卡伦博士是个特工 他是一名临床医生和研究人员，正是这种综合的专业知识帮助他成功地整合了UMB校园和整个马里兰州大学系统的癌症临床和研究活动。 博士卡伦在UMCCC的任期内，通过集中规划和招聘，临床和研究活动都有了显著的增长。在Cullen博士的领导下，UMCCC于2008年8月获得了第一个P30 CCSG。2010年，《美国新闻与世界报道》的“最佳医院”排名将UMCCC列在全国900多个癌症项目中的第21位，在该排名中，UMCCC在所有NCI指定中心中排名第18位。 2009年，卡伦博士被任命为美国癌症协会的国家委员会成员。 一个代表多个学科的优秀领导团队协助卡伦博士在战略规划，招聘，组织和运营的各个方面。 博士临床研究副主任爱德华·索斯维尔于2004年被招募。Sausville博士曾任NCI发展治疗学主任，在癌症药物开发方面享有杰出的国家声誉。自从他来到UMGCC，Sausville博士已经完全重组了临床研究 该中心与全国其他癌症中心建立了重要的战略联盟。 博士基础科学副主任艾伦·汤姆金森于2003年被招入UMCCC。他曾在德克萨斯大学圣安东尼奥分校癌症中心担任类似职位。除了作为DNA损伤和修复领域的研究人员的杰出专业知识。Tomkinson博士以前的经验对UMCCC重组的研究项目和计划的战略招聘非常宝贵。他还为初级教师制定并实施了一个指导过程。 先生Stephen Long是美国国立卫生研究院国家酒精中毒和酒精滥用研究所（NIAAA）的行政副主任，在担任了28年的管理员之后，于2006年被招募到UMCCC。在那里的最后8年里，他是该研究所的执行干事。Long先生对UMCCC的基础和临床研究运营以及总体预算的制定拥有全面的行政权力。他也有 慈善事业和政府关系的行政责任。 博士Mohan Suntharalingam，临床服务副主任，于2005年被任命。他是放射肿瘤学系的副主任，也是马里兰州大学RTOG基金的PI。 博士Suntharalingam对UMCCC的多学科临床项目进行行政监督，并在设计和实施多学科诊所以促进患者护理和临床研究方面发挥了重要作用。 博士共享服务总监Nicholas Ambulos长期担任UMSOM生物聚合物共享服务（现为基因组学共享服务）总监。2004年，卡伦博士聘请他担任UMCCC的共享服务总监。Ambulos博士在规划共享服务的发展、标准化运营和评估UMCCC调查人员的长期服务需求方面发挥了关键作用。 博士William Blattner于2010年被任命为人口科学副主任。Blattner博士也是人类病毒学研究所（IHV）的副主任和新成立的癌症流行病学部门的负责人。Blattner博士指导IHV在巴尔的摩和西非的临床和研究工作。Blattner博士曾担任NCI病毒流行病学分支主任。

Dr. Kevin Cullen was appointed director of UMGCC in 2004 after a national search. Dr. Cullen has an outstanding reputation as a clinician scientist, with focused interest in head and neck cancer biology and the mechanism of drug action and drug resistance. He had previously served as the acting director of the Lombardi Comprehensive Cancer Center at Georgetown University in Washington, DC. Dr. Cullen is an active clinician and researcher and it is that combined expertise which has helped him successfully integrate the cancer clinical and research activities on the UMB campus and across the University System of Maryland. Dr. Cullen's tenure at UMGCC has seen remarkable growth in both clinical and research activities through focused planning and recruitment. Under Dr. Cullen's leadership, UMGCC obtained its first P30 CCSG in August 2008. In 2010, the U.S. News & World Report "Best Hospitals" rankings listed UMGCC at #21 of more than 900 cancer programs in the country, and in this ranking, UMGCC was #18 of all NCI designated centers. In 2009, Dr. Cullen was appointed to the national board ofthe American Cancer Society. An outstanding leadership team representing multiple disciplines assists Dr. Cullen in all aspects of strategic planning, recruitment, organization and operation. Dr. Edward Sausville, associate director for Clinical Research, was recruited in 2004. Dr. Sausville was previously director of Developmental Therapeutics at NCI and has an outstanding national reputation in cancer drug development. Since his arrival at UMGCC, Dr. Sausville has completely reorganized the clinical research operations and formed critical strategic alliances with other cancer centers across the county. Dr. Alan Tomkinson, associate director for Basic Science, was recruited to UMGCC in 2003. He previously held a similar position at the Cancer Center, University of Texas-San Antonio. In addition to outstanding expertise as a researcher in the area of DNA damage and repair. Dr. Tomkinson's previous experience has been invaluable to the reorganized research programs at UMGCC and the planned strategic recruitments. He has also developed and implemented a mentoring process for junior faculty. Mr. Stephen Long, associate director for Administration, was recruited to UMGCC in 2006, after a 28-year tenure as an administrator at the National Institute for Alcoholism and Alcohol Abuse (NIAAA), NIH. In his last 8 years there, he was executive officer of that institute. Mr. Long has overall administrative authority for the basic and clinical research operations of UMGCC and the development of the overall budget. He also has administrative responsibility for philanthropy and government relations. Dr. Mohan Suntharalingam, associate director for Clinical Services, was appointed in 2005. He is vice chair of the Department of Radiation Oncology and is PI for the University of Maryland's RTOG grant. Dr. Suntharalingam has administrative oversight of UMGCC's multidisciplinary clinical programs and has been instrumental in designing and implementing multidisciplinary clinics to facilitate patient care and clinical research. Dr. Nicholas Ambulos, director of Shared Services, has long been the director of the Biopolymer Shared Service (now the Genomics Shared Service) at UMSOM. In 2004, Dr. Cullen recruited him to be director of Shared Services at UMGCC. Dr. Ambulos has played a critical role in planning the development of shared services, standardizing operations, and evaluating the long-term service needs of UMGCC investigators. Dr. William Blattner was appointed associate director for Population Science in 2010. Dr. Blattner is also associate director of the Institute of Human Virology (IHV) and Chief of the newly formed Division of Cancer Epidemiology. Dr. Blattner directs clinical and research efforts of the IHV in Baltimore and West Africa. Dr. Blattner previously served as Chief ofthe Viral Epidemiology Branch at NCI.